Buprenorphine screening can give cross-reactive false positives, and clinical or legal decisions require definitive identification. Confirmation testing identifies both buprenorphine and its norbuprenorphine metabolite, distinguishing genuine compliance with therapy from cross-reactive substances.
This test is used in medication-assisted treatment programs, addiction medicine, pain management, and forensic testing. Sample type is urine, often under chain-of-custody protocols.
We are CLIA certified, the highest level of Medical industry compliance and standards.
Book an appointment